Table 2.
Country | SIA | MCV1 |
MCV1 Mean | ||||
---|---|---|---|---|---|---|---|
DHS/MICS 2 rounds before SIA |
DHS/MICS round before SIA |
DHS/MICS round during SIA |
DHS/MICS round after SIA |
DHS/MICS 2 rounds after SIA |
|||
(2002–2012) | (1993–2003) | (1997–2008) | (2002–2014) | (2006–2014) | (2008–2014) | ||
Benin | 2.6 | NA | 5.9 | 15 | 13.6 | 14.5 | 10.3 |
Burkina Faso | 1.5 | 0.6 | 4 | 12.9 | 4.9 | 7.7 | 5.3 |
Cameroon | ‒7.6 | NA | 10.8 | 23.7 | NA | NA | 8.9 |
Democratic Republic of the Congo | 5.6 | NA | 2.6 | 18.8 | 10.4 | 12.8 | 10 |
Ghana (2003) | 6.7 | ‒3.8 | 13.5 | 9.5 | 12.1 | 4.4 | 7.1 |
Ghana (2008) | 5.6 | 9.5 | 12.1 | 4.4 | 3.3 | 2.7 | 6.3 |
Guinea | 9.8 | NA | 5.3 | 15.1 | 13.2 | NA | 10.9 |
Guinea-Bissau | 3.4 | NA | 10.3 | 10.6 | NA | NA | 8.1 |
Haiti | 0.3 | NA | 15.8 | 9.6 | 0.9 | NA | 6.7 |
Honduras | ‒0.7 | NA | NA | 1.1 | 1.2 | NA | 0.5 |
Indonesia | 8.9 | NA | 10.8 | 11.3 | 12.7 | 12.1 | 11.2 |
Iraq | 0.9 | NA | NA | 10.1 | NA | NA | 5.5 |
Kenya | 3.3 | 2.2 | ‒3.4 | 11.7 | 6.6 | 7.9 | 4.7 |
Lesotho | 2.5 | NA | ‒2.9 | 3.6 | 8.7 | 3.3 | 3.0 |
Nepal | 0.3 | 4.7 | 10.2 | 11.5 | 6 | 8.6 | 6.9 |
Niger | 5.3 | NA | ‒2.9 | 15.4 | 10.8 | NA | 7.2 |
Nigeria | 4.0 | 20.4 | 20.2 | 25.5 | 25.2 | 27.7 | 20.5 |
São Tomé and Príncipe (2008) | 4.2 | NA | NA | 3.9 | 11.6 | NA | 6.6 |
São Tomé and Príncipe (2014) | ‒0.2 | NA | 3.9 | 11.6 | NA | NA | 5.1 |
Sierra Leone | 1.8 | NA | 8.1 | 6.1 | 0.3 | 1.4 | 3.5 |
Vanuatu | 5.0 | NA | NA | 14.3 | NA | NA | 9.7 |
Vietnam | 4.0 | NA | 8.9 | 5.6 | 10.0 | NA | 7.2 |
Mean (SD) | 3.1 (3.7) | 5.6 (8.5) | 7.4 (6.5) | 11.4 (6.2) | 8.9 (6.1) | 9.4 (7.5) | 7.5 (3.9) |
DHS indicates Demographic Health Survey; MCV1, routine measles-containing vaccine, first dose; MICS, Multiple Indicator Cluster Surveys; NA, not applicable; SIA, supplementary immunization activities.
Two different SIAs were included in the analysis for the countries of Ghana and São Tomé and Príncipe.